Table 3.
Parameters | Group | Before Treatment | After Treatment |
---|---|---|---|
Creatinine [mg/dL] | Placebo | 0.74 ± 0.02 | 0.78 ± 0.03 |
G1 | 0.81 ± 0.03 | 0.83 ± 0.04 | |
G2 | 0.76 ± 0.04 | 0.78 ± 0.04 | |
Bilirubin [mg/dL] | Placebo | 0.64 ± 0.08 | 0.65 ± 0.05 |
G1 | 0.71 ± 0.12 | 0.64 ± 0.09 | |
G2 | 0.65 ± 0.09 | 0.80 ± 0.13 | |
ALT [U/L] | Placebo | 33.30 ± 4.50 | 32.68 ± 6.70 |
G1 | 24.77 ± 3.00 | 23.24 ± 3.10 | |
G2 | 26.82 ± 1.90 | 26.59 ± 2.19 | |
AST [U/L] | Placebo | 25.63 ± 1,48 | 26.37 ± 4.00 |
G1 | 28.48 ± 4.69 | 26.14 ± 3.90 | |
G2 | 22.47 ± 1.12 | 22.82 ± 1.24 |